Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senators Ask Why GMP Compliance Eludes Dietary Supplement Firms

This article was originally published in The Tan Sheet

Executive Summary

Democrats Durbin and Blumenthal raise concerns about the “pervasiveness of poor manufacturing standards” in the supplement industry and demand to know what trade groups will do to improve compliance with good manufacturing practices.

You may also be interested in...



Basic Supplement GMP Compliance Problems Continue In FDA Warnings

The agency posts warning letters sent Jan. 23 to Herbal Science International Inc. in City of Industry, Calif. and Jan. 31 to Berkeley Nutritional Manufacturing Corp. in Livermore, Calif.

Better Supplement Industry Self-Regulation Slows Enforcement 'Hammer' –Indiana AG

"I'm a big advocate of industry self-regulation. Government is kind of a blunt instrument," Indiana AG Greg Zoeller says before speaking at a conference on supplement industry regulation. He says increased supply chain integrity is needed because "there's a lot of, 'We tested a little bit of it but then we didn't test'."

Curb Enforcement 'Hammer' With Better Self-Regulation, Indiana AG Urges Supplement Firms

"I'm a big advocate of industry self-regulation. Government is kind of a blunt instrument," Indiana AG Greg Zoeller says before speaking at a conference on supplement industry regulation. He says increased supply chain integrity is needed because "there's a lot of, 'We tested a little bit of it but then we didn't test'."

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel